GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T45.525D
Adverse effect of antithrombotic drugs, subsequent encounter
ICD10CM code
Similar Codes
ICD10CM codes
T45.525D
- Adverse effect of antithrombotic drugs, subsequent encounter
T45.525A
- Adverse effect of antithrombotic drugs, initial encounter
T45.515D
- Adverse effect of anticoagulants, subsequent encounter
T45.615D
- Adverse effect of thrombolytic drugs, subsequent encounter
T45.625D
- Adverse effect of hemostatic drug, subsequent encounter
T45.515A
- Adverse effect of anticoagulants, initial encounter
T45.525S
- Adverse effect of antithrombotic drugs, sequela
T45.525
- Adverse effect of antithrombotic drugs
T45.526D
- Underdosing of antithrombotic drugs, subsequent encounter
T45.7X5D
- Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
HCPCS codes
G8696
- Antithrombotic therapy prescribed at discharge
G8969
- Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoa
G8697
- Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospit
G9724
- Patients who had documentation of use of anticoagulant medications overlapping the measurement year
G8968
- Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulan
G8972
- One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboe
G9928
- Warfarin or another fda-approved anticoagulant not prescribed, reason not given
G8971
- Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
G8967
- Warfarin or another fda approved oral anticoagulant is prescribed
C1757
- Catheter, thrombectomy/embolectomy
CPT4 codes
85301
- Clotting inhibitors or anticoagulants; antithrombin III, antigen assay
4011F
- Oral antiplatelet therapy prescribed (CAD)
36593
- Declotting by thrombolytic agent of implanted vascular access device or catheter
85300
- Clotting inhibitors or anticoagulants; antithrombin III, activity
37195
- Thrombolysis, cerebral, by intravenous infusion
85210
- Clotting; factor II, prothrombin, specific
34421
- Thrombectomy, direct or with catheter; vena cava, iliac, femoropopliteal vein, by leg incision
34401
- Thrombectomy, direct or with catheter; vena cava, iliac vein, by abdominal incision
85305
- Clotting inhibitors or anticoagulants; protein S, total
92977
- Thrombolysis, coronary; by intravenous infusion